Global Microcarrier Market Database: By Company Name, Headquarter, Year of Incorporation, Ticker Symbol, Stock Exchange, Industry Type, and Microcarrier Application

Global Microcarrier Market Database is a new subscription offering from Global Insight Services that offers tracking of pharma and biotech companies that use microcarriers. Subscribers to this service receive access to updates to the company database every month.

Microcarriers are small, typically spherical particles made from materials such as dextran, polystyrene, or glass, designed to support the growth of anchorage-dependent cells in bioreactors. These cells require a surface to adhere to for growth and proliferation, which is provided by microcarriers. In biotechnology and cell culture applications, microcarriers serve as a substrate for cells to attach to and grow in suspension culture systems, allowing for the production of large quantities of cells in a controlled environment. Microcarriers are commonly used in the production of vaccines, therapeutic proteins, and other biopharmaceuticals, as well as in tissue engineering and regenerative medicine research. They offer advantages such as scalability, increased surface area for cell attachment, and ease of handling during cell culture processes.

Key Benefits
  • Provides detailed information on all pharma and biotech companies that use microcarriers globally on a live basis.
  • Assess competitor actions and gain insight into your market positioning.
  • Provides detailed data on companies, including their name, headquarters location, year of incorporation, ticker symbol, and stock exchange listing.
  • Offers insights into the biotechnology and pharmaceutical industries, including key players and their market presence.
  • Helps track trends in microcarrier applications across different sectors, including life sciences, genomics, drug development, gene therapies, ophthalmology, antibody discovery, and drug development.
  • Enables comparison of companies within the microcarrier market, aiding in understanding their strengths, weaknesses, and competitive positioning.
  • Supports research and development efforts by providing insights into companies involved in microcarrier technology and their areas of focus.
Database Coverage
  • More than 1100 companies are listed and more are being added daily
  • Around 30 countries listed
  • Company Information
    • Company Name
    • Headquarter
    • Year of Incorporation
    • Ticker Symbol
    • Stock Exchange
    • Industry Type
    • Microcarrier Application
Major Microcarrier Manufacturers

Some of the major manufacturers of the microcarrier market include Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Sartorius AG, Cytiva, Pall Corporation (a Danaher company), Greiner Bio-One, FiberCell Systems, Repligen Corporation, Irvine Scientific, CellGenix GmbH, Lonza Group, Takara Bio Inc., Kuraray Co., Ltd., FUJIFILM Holdings Corporation, and Eppendorf SE, among others.

Key Microcarrier Users

Some of the key companies use microcarriers as an application include Johnson & Johnson, Pfizer Inc., Novartis AG, Hoffmann-La Roche Ltd, AstraZeneca, Sanofi Group, Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., Biogen, Gilead Sciences, Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Moderna, Inc., BioMarin, Incyte Corporation, Alnylam Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc., among others.

By Industry Type

The industry type is categorized into pharmaceuticals, biotechnology, and others.

By Microcarrier Application

The microcarrier application is classified into cell therapy, gene therapy, drug development & drug discovery, stem cells, tissue engineering, regenerative medicines, vaccine production, biopharmaceutical production, therapeutics, and others.

By Region

Region-wise, the microcarrier market is categorized into North America, Europe, and Asia-Pacific. The North America region is categorized into the United States and Canada. The Europe region is segmented into Spain, the United Kingdom, Switzerland, Germany, Ireland, the Netherlands, Denmark, Belgium, Luxembourg, Sweden, France, Austria, Italy, Finland, Norway, Slovenia, Scotland, the Czech Republic, and Russia. The Asia-Pacific region is China, South Korea, Australia, India, Japan, Taiwan, and Singapore.

Recent Developments
  • In January 2024, Bio-Techne Corporation exhibits its cell and gene therapy solutions at Phacilitate’s Advanced Therapies Week from January 16–19 at the Miami Beach Convention Centre. Their booth features FluorokinesTM proteins, multi-color flow cytometry panels for CAR-T and CAR-NK cell analysis, RNAscopeTM assays for therapeutic visualization, GMP media and liquid cytokines for immune cell expansion, and automated instruments for product characterization and in vivo monitoring.
  • In January 2024, The Israeli biotechnology startup, Pluri unveiled the establishment of PluriCDMO, a fresh business segment dedicated to delivering cell therapy manufacturing services as a Contract Development and Manufacturing Organization (CDMO). Integral to this expansion is a state-of-the-art, 47,000-square-foot facility adhering to Good Manufacturing Practice (GMP) standards, aimed at bolstering cell therapy production within the company.
  • In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers tailored for use in regenerative medicine cell cultures. Scheduled for release in January 2024 in Japan and subsequently in other nations, beginning with the US, these microcarriers offer a novel approach. The PVA hydrogel microcarriers facilitate efficient cell detachment and recovery as cells adhere to and proliferate on their surface upon placement in the bioreactor for large-scale cell culture. Demonstrating enhanced cell culture efficacy, our microcarriers have undergone rigorous safety testing and exhibit resilience even under bioreactor agitation.
  • In October 2023, Semarion Ltd., a spin-out from the University of Cambridge’s Cavendish Laboratory, introduced its Early Adopter Programme for the SemaCyte Microcarrier Platform. This initiative merges materials engineering and cell biology to tackle unmet requirements in drug screening. By allowing small cell colonies to be transported and frozen while still adhering, the platform enhances data yield per experiment and reduces the resource burden of in vitro drug discovery. This addresses existing constraints related to adherent cell culture and assay workflows.
  • In July 2023, Cytoniche Bioscience’s 3D TableTrix® Microcarriers, designated with file number 037798, obtained FDA Type II Drug Master File (DMF) registration. This enables their utilization as active pharmaceutical ingredients (APIs), expanding their role beyond pharmaceutical excipients. These microcarriers can now contribute to medication formulations and may exert pharmacological effects or influence the human body’s composition and functionality.
  • In June 2023, Teijin Frontier developed an innovative nonwoven microcarrier technology that differs from traditional weaving methods. This advancement, originating from the fiber and product conversion division of the Teijin Group, is designed to streamline the production of extensive cell cultures of superior quality. The primary function of this novel scaffolding material is to enhance three-dimensional adhesion and growth for various types of cells.
  • In March 2023, Soluble microcarriers serve as scaffolding agents in cell culture methodologies, facilitating the generation of cell and gene-based products, exosomes, biopharmaceuticals, and cultured meat. Developed by Dai Nippon Printing Co., Ltd. (DNP) and Hyperion Drug Discovery Co., Ltd. (HDD), known for their advancements in regenerative medicine and gene therapy, these microcarriers play a pivotal role in supporting various applications within the field.
Database Coverage
  • More than 1100 companies are listed and more are being added daily
  • Around 30 countries listed
  • Company Information
    • Company Name
    • Headquarter
    • Year of Incorporation
    • Ticker Symbol
    • Stock Exchange
    • Industry Type
    • Microcarrier Application
Major Microcarrier Manufacturers
  • Thermo Fisher Scientific
  • Corning Incorporated
  • Merck KGaA
  • Sartorius AG
  • Cytiva
  • Pall Corporation (a Danaher company)
  • Greiner Bio-One
  • FiberCell Systems
  • Repligen Corporation
  • Irvine Scientific
  • CellGenix GmbH
  • Lonza Group
  • Takara Bio Inc.
  • Kuraray Co., Ltd.
  • FUJIFILM Holdings Corporation
  • Eppendorf SE
Key Microcarrier Users
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Hoffmann-La Roche Ltd
  • AstraZeneca
  • Sanofi Group
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Biogen
  • Gilead Sciences, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Vertex Pharmaceuticals Incorporated
  • Moderna, Inc.
  • BioMarin
  • Incyte Corporation
  • Alnylam Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
By Industry Type
  • Pharmaceuticals
  • Biotechnology
  • Others
By Microcarrier Application
  • Cell Therapy
  • Gene Therapy
  • Drug Development & Drug Discovery
  • Stem Cells
  • Tissue Engineering
  • Regenerative Medicines
  • Vaccine Production
  • Biopharmaceutical Production
  • Therapeutics
  • Others
By Region
  • North America
    • The United States
    • Canada
  • Europe
    • Spain
    • The United Kingdom
    • Switzerland
    • Germany
    • Ireland
    • The Netherlands
    • Denmark
    • Belgium
    • Luxembourg
    • Sweden
    • France
    • Austria
    • Italy
    • Finland
    • Norway
    • Slovenia
    • Scotland
    • The Czech Republic
    • Russia
  • Asia-Pacific
    • China
    • South Korea
    • Australia
    • India
    • Japan
    • Taiwan
    • Singapore

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

The global Immune Cell Engineering Market size was…
Shoulder replacement is a surgical procedure that replaces…
PET Radiotracer is a type of imaging technique…
Vitamin D therapy is a form of treatment…
Acute Myeloid Leukemia (AML, Acute Myeloblastic Leukemia) is…
Dental laboratories are businesses that provide dental products…
Life science tools are instruments, software, and other…
G-Protein Coupled Receptors (GPCR) are a type of…
Glioblastoma multiforme (GBM) is an aggressive type of…
Protein characterization and identification is the process of…